Teva, American Zurich, BuzzBallz: Intellectual Property

Updated on

Four pharmaceutical companies have asked a federal appeals court for an expedited ruling on the validity of a patent covering an injectable drug used to treat multiple sclerosis.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.